UBS OCONNOR LLC - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,559,222
-13.9%
93,816
-3.1%
0.04%
-31.6%
Q2 2023$1,810,459
+7.2%
96,816
+5.2%
0.06%
+9.6%
Q1 2023$1,689,044
-99.9%
92,046
+31.8%
0.05%
+62.5%
Q3 2022$1,680,000,000
+16.9%
69,812
-11.3%
0.03%
+52.4%
Q2 2022$1,437,000,000
+574.6%
78,750
+687.5%
0.02%
+425.0%
Q1 2020$213,000,00010,0000.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ponoi Management, LLC 1,599,417$29,189,00046.08%
KPCB XV Associates, LLC 1,297,063$23,671,00043.66%
Column Group LLC 2,680,458$48,918,00010.41%
Ponoi II Management, LLC 145,401$2,654,0007.21%
Euclidean Capital LLC 432,900$7,900,0006.72%
AJU IB Investment Co., Ltd. 99,503$1,816,0003.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,023,321$18,676,0003.17%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 443,619$8,096,0001.62%
Ghost Tree Capital, LLC 165,000$3,011,0001.57%
Perceptive Advisors 1,913,791$34,927,0001.09%
View complete list of RAPT THERAPEUTICS INC shareholders